Clinical Trial Update: Quadratus Lumborum Block for Percutaneous Nephrostomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating quadratus lumborum block for pain management during percutaneous nephrostomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Urinary Tract Obstruction

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Nephrostomy; Complications, Upper Urinary Tract Dilatation and Obstruction | Phase 4 | Status: WITHDRAWN